Carbohydrate metabolism in normal and hyperglycemic animals treated with 1-methyl-4-(3-methyl-5-isoxazolyl)pyridinium chloride and phenformin.
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002219:Carbamates / Q000494:pharmacology; D050260:Carbohydrate Metabolism; D003920:Diabetes Mellitus / Q000503:physiopathology; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D004195:Disease Models, Animal; D005215:Fasting; D005944:Glucosamine / Q000494:pharmacology; D006003:Glycogen / Q000032:analysis; D006029:Glycosuria; D006168:Guinea Pigs; D006943:Hyperglycemia / Q000139:chemically induced / Q000378:metabolism*; D007003:Hypoglycemia / Q000139:chemically induced / Q000378:metabolism*; D007773:Lactates / Q000097:blood; D008112:Liver Glycogen / Q000032:analysis; D008297:Male; D051379:Mice; D009603:Nitroso Compounds / Q000494:pharmacology; D009765:Obesity; D010080:Oxazoles / Q000494:pharmacology*; D010629:Phenformin / Q000494:pharmacology*; D011726:Pyridinium Compounds / Q000494:pharmacology*; D051381:Rats
D001786:Blood Glucose; D002219:Carbamates; D007773:Lactates; D008112:Liver Glycogen; D009603:Nitroso Compounds; D010080:Oxazoles; D011726:Pyridinium Compounds; D006003:Glycogen; D010629:Phenformin; D005944:Glucosamine